Tag: Compounded

FDA panel backs compounded BPC-157, KPV peptides in win for RFK Jr.

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the

FDA says ‘no clinical need’ for compounded weight loss drugs

The Food and Drug Administration has suggested removing the active ingredients found in popular obesity and diabetes medications

Hims & Hers won’t sell compounded version of Novo’s obesity pill

Hims & Hers made a controversial decision to stop selling a compounded version of Novo Nordisk’s obesity pill

Super Bowl Ad Raises Questions About Compounded V. Brand Obesity Meds

The ongoing debate surrounding the use of compounded weight loss drugs as a more affordable alternative to branded